✦ LIBER ✦
634 POSTER Post-study treatment does not influence outcome in the X-ACT phase III trial of capecitabine (X) vs. bolus 5-FU/LV as adjuvant therapy for patients (pts) with Dukes' C colon cancer
- Book ID
- 118623211
- Publisher
- Elsevier Science
- Year
- 2005
- Tongue
- English
- Weight
- 141 KB
- Volume
- 3
- Category
- Article
- ISSN
- 1359-6349
No coin nor oath required. For personal study only.